The state Supreme Court has rejected the request of a pharmaceutical manufacturer to exercise its jurisdiction over whether Pennsylvania is the most convenient forum for several drug products liability cases brought by out-of-state plaintiffs in Philadelphia Common Pleas Court.
The Supreme Court rejected the request without comment in orders issued late in the business day Wednesday. The orders were entered in nine cases in which the plaintiffs allege that taking drugmaker Bayer’s Yaz and Yasmin birth control pills caused their injuries.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
